Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 745046-84-8
2. Caspase-3 Inhibitor Vii
3. 2-(4-methyl-8-morpholin-4-ylsulfonyl-1,3-dioxopyrrolo[3,4-c]quinolin-2-yl)ethyl Acetate
4. 2-(4-methyl-8-(morpholin-4-ylsulfonyl)-1,3-dioxo-1,3-dihydro-2h-pyrrolo[3,4-c]quinolin-2-yl)ethyl Acetate
5. 2-[4-methyl-8-(morpholin-4-ylsulfonyl)-1,3-dioxo-1,3-dihydro-2h-pyrrolo[3,4-c]quinolin-2-yl]ethyl Acetate
6. Mls006013365
7. Chembl192330
8. Schembl8312700
9. Bdbm10358
10. Chebi:93128
11. Dtxsid80458580
12. Hms3269h15
13. Bcp17017
14. Hy-p1095
15. Veb04684
16. Zinc6718487
17. Akos021734943
18. Ncgc00167805-01
19. Ncgc00167805-02
20. Smr004704848
21. Pyrrolo[3,4-c]-quinoline-1,3-dione 7a
22. Cs-0027701
23. Ft-0729441
24. E98800
25. Caspase-3 Inhibitor Vii - Cas 745046-84-8
26. Brd-k64402243-001-01-1
27. Q27164850
28. 2-(4-methyl-8-(morpholinosulfonyl)-1,3-dioxo-1h-pyrrolo[3,4-c]quinolin-2(3h)-yl)ethyl Acetate
29. 2-[4-methyl-8-(morpholin-4-ylsulfon Yl)-1,3-dioxo-1,3-dihydro-2h-pyrrolo[3,4-c]quinolin-2-yl]ethyl Acetate
30. 2-[4-methyl-8-(morpholinosulfonyl)-1,3-dioxo-1,3-dihydro-2h-pyrrolo[3,4-c]quinolin-2-yl]ethyl Acetate
31. 2-[7-methyl-12-(morpholine-4-sulfonyl)-3,5-dioxo-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaen-4-yl]ethyl Acetate
32. 4-[[2-[2-(acetyloxy)ethyl]-2,3-dihydro-4-methyl-1,3-dioxo-1h-pyrrolo[3,4-c]quinolin-8-yl]sulfonyl]-morpholine
33. Acetic Acid 2-[4-methyl-8-(4-morpholinylsulfonyl)-1,3-dioxo-2-pyrrolo[3,4-c]quinolinyl]ethyl Ester
| Molecular Weight | 447.5 g/mol |
|---|---|
| Molecular Formula | C20H21N3O7S |
| XLogP3 | 0.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 6 |
| Exact Mass | 447.11002119 g/mol |
| Monoisotopic Mass | 447.11002119 g/mol |
| Topological Polar Surface Area | 132 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 836 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
100
PharmaCompass offers a list of Ivachtin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ivachtin manufacturer or Ivachtin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ivachtin manufacturer or Ivachtin supplier.
PharmaCompass also assists you with knowing the Ivachtin API Price utilized in the formulation of products. Ivachtin API Price is not always fixed or binding as the Ivachtin Price is obtained through a variety of data sources. The Ivachtin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ivachtin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ivachtin, including repackagers and relabelers. The FDA regulates Ivachtin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ivachtin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ivachtin supplier is an individual or a company that provides Ivachtin active pharmaceutical ingredient (API) or Ivachtin finished formulations upon request. The Ivachtin suppliers may include Ivachtin API manufacturers, exporters, distributors and traders.
Ivachtin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ivachtin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ivachtin GMP manufacturer or Ivachtin GMP API supplier for your needs.
A Ivachtin CoA (Certificate of Analysis) is a formal document that attests to Ivachtin's compliance with Ivachtin specifications and serves as a tool for batch-level quality control.
Ivachtin CoA mostly includes findings from lab analyses of a specific batch. For each Ivachtin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ivachtin may be tested according to a variety of international standards, such as European Pharmacopoeia (Ivachtin EP), Ivachtin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ivachtin USP).